Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: health – Page 38

Microbes that are used for health, agricultural, or other applications need to be able to withstand extreme conditions, and ideally the manufacturing processes used to make tablets for long-term storage. MIT researchers have now developed a new way to make microbes hardy enough to withstand these extreme conditions.

Their method involves mixing bacteria with food and drug additives from a list of compounds that the FDA classifies as “generally regarded as safe.” The researchers identified formulations that help to stabilize several different types of microbes, including yeast and bacteria, and they showed that these formulations could withstand high temperatures, radiation, and industrial processing that can damage unprotected microbes.

Read more | >

The structure and function of the kidneys is altered by space flight, with galactic radiation causing permanent damage that would jeopardise any mission to Mars, according to a new study led by researchers from UCL.

The study, published in Nature Communications, is the largest analysis of kidney health in space flight to date and includes the first health dataset for commercial astronauts. It is published as part of a Nature special collection of papers on space and health.

Researchers have known that space flight causes certain health issues since the 1970s, in the years after humans first travelled beyond Earth’s magnetic field, most famously during the first moon landing in 1969. These issues include loss of bone mass, weakening of the heart and eyesight, and development of kidney stones.

Read more | >

Editor’s note: Video above is about a NASA astronaut discussing an extended stay in space.

(THE CONVERSATION) – Only about 600 people have ever traveled to space. The vast majority of astronauts over the past six decades have been middle-aged men on short-duration missions of fewer than 20 days.

Today, with private, commercial and multinational spaceflight providers and flyers entering the market, we are witnessing a new era of human spaceflight. Missions have ranged from minutes, hours and days to months.

Read more | >

As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small discusses systemic therapy treatment in advanced prostate cancer, including AR-targeted therapy. The presentation includes definitions of disease states, categories of treatment types, and standards in treatment selection.
Recorded on 03/09/2024. [Show ID: 39768]

Donate to UCTV to support informative \& inspiring programming:
https://www.uctv.tv/donate.

Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.

More videos from: Prostate Cancer Patient Conference.

Continue reading “Systemic Therapy Approaches for Advanced Prostate Cancer” | >

Microbes that are used for health, agricultural, or other applications need to be able to withstand extreme conditions, and ideally the manufacturing processes used to make tablets for long-term storage. MIT researchers have now developed a new way to make microbes hardy enough to withstand these extreme conditions.

Their method involves mixing bacteria with food and drug additives from a list of compounds that the FDA classifies as “generally regarded as safe.” The researchers identified formulations that help to stabilize several different types of microbes, including yeast and bacteria, and they showed that these formulations could withstand high temperatures, radiation, and industrial processing that can damage unprotected microbes.

In an even more extreme test, some of the microbes recently returned from a trip to the International Space Station, coordinated by Space Center Houston Manager of Science and Research Phyllis Friello, and the researchers are now analyzing how well the microbes were able to withstand those conditions.

Read more | >

Researchers have developed a novel 3D stretchable electronic strip which is expected to open up a range of new possibilities in wearable electronic textiles.

A team at Nottingham Trent University’s Medical Technologies Innovation Facility has led the work, which has paved the way for a new generation of electronic devices which could be embedded in clothing for possible use in health care and elite sports settings.

The research, which also involved industry partner Kymira Ltd, is published in Scientific Reports.

Read more | >

A compact, lightweight sensor system with infrared imaging capabilities developed by an international team of engineers could be easily fitted to a drone for remote crop monitoring.

This flat-optics technology has the potential to replace traditional optical lens applications for environmental sensing in a range of industries.

This innovation could result in cheaper groceries as farmers would be able to pinpoint which crops require irrigation, fertilization and pest control, instead of taking a one-size-fits-all approach, thereby potentially boosting their harvests.

Read more | >

The four volunteers who have been living and working inside NASA’s first simulated yearlong Mars habitat mission are set to exit their ground-based home on Saturday, July 6. NASA will provide live coverage of the crew’s exit from the habitat at NASA’s Johnson Space Center in Houston at 5 p.m. EDT.

NASA will stream the activity, which will include a short welcome ceremony, on NASA+, NASA Television, the NASA app, the agency’s website, and NASA Johnson’s X and Facebook accounts. Learn how to stream NASA TV through a variety of platforms, including social media.

The first Crew Health and Performance Exploration Analog (CHAPEA) mission began in the 3D printed habitat on June 25, 2023, with crew members Kelly Haston, Anca Selariu, Ross Brockwell, and Nathan Jones. For more than a year, the crew simulated Mars mission operations, including “Marswalks,” grew and harvested several vegetables to supplement their shelf-stable food, maintained their equipment and habitat, and operated under additional stressors a Mars crew will experience, including communication delays with Earth, resource limitations, and isolation.

Read more | >

This study uncoversthe pivotal role of the enzyme METTL4 in promoting tumor metastasis through the mediation of nuclear N6-methyldeoxyadenosine (6mA) in mammalian cells. By utilizing cellular models, the study demonstrates how hypoxia induces METTL4 to mediate 6mA modifications. This process, in turn, activates genes essential for tumor metastasis, including the involvement of specific long noncoding RNA and a novel HIF-1α co-activator, ZMIZ1. These findings not only shed light on the epigenetic mechanisms driving tumor progression but also establish METTL4 as a prognostic marker for cancer and a potential target for therapeutic intervention. The promise of this discovery lies in its potential to inspire new strategies for combating hypoxia-induced tumor progression, opening avenues for further research and development in cancer treatment.

DNA N6-methyldeoxyadenosine (6mA) has been recognized in various organisms for its role in gene regulation. However, its function in mammalian cells, particularly in the context of cancer, has remained elusive. Previous studies have shown that 6mA modifications can influence gene expression and are present in several species, indicating a potential regulatory role in tumorigenesis. This research addresses a critical gap in understanding the nuclear role of 6mA and its enzymatic mediator METTL4, in mammalian tumor cells, particularly under hypoxia (a common condition in tumor microenvironments that promotes metastasis). The study posits that METTL4-mediated 6mA deposition is a key epigenetic modification that activates metastasis-inducing genes. This finding offers a new perspective on the mechanisms of tumor progression and identifying novel targets for therapeutic intervention.

According to recent World Health Organization statistics, cancer remains a leading cause of death globally, with metastatic cancers posing significant treatment challenges. This study’s revelations underscore the urgent need for novel therapeutic strategies to address the complex mechanisms of cancer metastasis. By linking the research findings to SDG 3, which aims to ensure healthy lives and promote well-being for all, the study highlights the potential for significant advancements in cancer treatment. Ultimately, the study paves the way for improved health outcomes and underscores the importance of continued investment in research and development to combat the global cancer burden.

Read more | >

Scientists at Duke-NUS Medical School have identified how the first domino falls after a person encounters an allergen, such as peanuts, shellfish, pollen or dustmites. Their discovery, published in the April issue of Nature Immunology, could herald the development of drugs to prevent these severe reactions.

It is well established that when mast cells, a type of immune cell, mistake a harmless substance, such as peanuts or dust mites, as a threat, they release an immediate first wave of bioactive chemicals against the perceived threat. When mast cells, which reside under the skin, around blood vessels and in the linings of the airways and the gastrointestinal tract, simultaneously release their pre-stored load of bioactive chemicals into the blood, instant and systemic shock can result, which can be lethal without quick intervention.

More than 10 per cent of the global population suffers from food allergies, according to the World Health Organisation (WHO). As allergy rates continue to climb, so does the incidence of food-triggered anaphylaxis and asthma worldwide. In Singapore, asthma affects one in five children while food allergies are already the leading cause of anaphylactic shock.

Read more | >